1,958 hedge funds and large institutions have $144B invested in Pfizer in 2016 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 884 increasing their positions, 762 reducing their positions, and 81 closing their positions.

New
Increased
Maintained
Reduced
Closed

more repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less ownership

Funds ownership:

less call options, than puts

Call options by funds: $ | Put options by funds: $

less first-time investments, than exits

New positions opened: | Existing positions closed:

1% less funds holding

Funds holding: 1,9871,958 (-29)

5% less capital invested

Capital invested by funds: $152B → $144B (-$8.2B)

18% less funds holding in top 10

Funds holding in top 10: 285234 (-51)

Holders
1,958
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
234
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$2.25B
Puts
$2.33B
Net Calls
Net Calls Change

Top Buyers

1 +$337M
2 +$327M
3 +$270M
4
Renaissance Technologies
Renaissance Technologies
New York
+$231M
5
JP Morgan Chase
JP Morgan Chase
New York
+$176M
Name Holding Trade Value Shares
Change
Change in
Stake
1751
$308K
1752
$307K
1753
$307K
1754
$306K
1755
$305K
1756
$305K
1757
$304K
1758
$304K
1759
$304K
1760
$303K
1761
$301K
1762
$297K
1763
$295K
1764
$294K
1765
$294K
1766
$294K
1767
$294K
1768
$293K
1769
$291K
1770
$291K
1771
$291K
1772
$291K
1773
$290K
1774
$285K
1775
$285K